Therefore, we conclude that the serum concentrations of IFN-α and IL-33 may serve as biomarkers for the diagnosis of type 1 AIP/IgG4-RD, as well as for monitoring purposes. The gene discussed is IL33; the disease is immunoglobulin G4-related sclerosing disease.